Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse  >  Abbott Laboratories    ABT

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Sales39 87421 84820 24720 65721 81923 168
Operating income (EBITDA)12 6164 9745 8625 1025 6026 119
Operating profit (EBIT)9 8334 0464 3144 0384 5324 924
Pre-Tax Profit (EBT)6 2632 521----
Net income5 9632 5762 2843 5803 2033 540
PER---24,421,119,0
EPS ( $)3,721,621,491,872,162,40
Dividend per Share ( $)1,670,640,900,951,041,15
Yield3,66%1,40%1,97%2,09%2,28%2,53%
Announcement Date01/23/2013
12:47pm
01/22/2014
12:44pm
01/29/2015
12:45pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Debt9 6743 0863 782386616278
Finance------
Operating income (EBITDA)12 6164 9745 8625 1025 6026 119
Leverage
(Debt/EBITDA)
0,77x0,62x0,65x0,08x0,11x0,05x
Capital Expenditure1 7951 1451 0771 1011 1581 218
Book Value Per Share (BVPS)17,0 $16,3 $14,3 $17,2 $18,3 $18,7 $
Cash Flow per Share5,85 $2,11 $2,41 $2,73 $3,03 $3,58 $
Announcement Date01/23/2013
12:47pm
01/22/2014
12:44pm
01/29/2015
12:45pm
---
Balance Sheet Analysis
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 68 024 M$ -
Entreprise Value (EV) 68 409 M$ 68 639 M$
Valuation 2015e 2016e
PER (Price / EPS) 24,4x 21,1x
Capitalization / Revenue 3,29x 3,12x
EV / Revenue 3,31x 3,15x
EV / EBITDA 13,4x 12,3x
Yield (DPS / Price) 2,09% 2,28%
Price to book (Price / BVPS) 2,65x 2,49x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 19,5% 20,8%
operating Leverage (Delta EBIT / Delta Sales) - 2,17x
Net Margin (Net Profit / Revenue) 17,3% 14,7%
ROA (Net Profit / Asset) 7,50% 8,04%
ROE (Net Profit / Equities) 13,6% 13,8%
Rate of Dividend 50,8% 48,1%
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   5,33% 5,31%
Cash Flow / Sales (Taux d'autofinancement) 19,7% 20,7%
Capital Intensity (Assets / Sales) 2,31x 1,83x
Financial Leverage (Net Debt / EBITDA) 0,08x 0,11x
Price Earning Ratio
EPS & Dividend